 |
| Thomas Nilsson, managing director HEXPOL TPE AB and Georg Brunstam, President and CEO HEXPOL Group, with members of the HEXPOL board and local management team in Åmål |
HEXPOL TPE has announced a 57 Million SEK investment at their company in Åmål, Sweden, to support increasing demand and evolving market requirements. The investment will expand production capacity and ensure product safety standards across their materials portfolio.
The Swedish company specialises in Thermoplastic Elastomer (TPE) materials for sensitive and regulated applications such as medical devices, toys, consumer, automotive and food contact. Sustainability and biobased materials are also driving their strategy.
A new production hall is being constructed, dedicated to medical production, with strict cleanliness, traceability, and reproducibility controls. It has been designed to minimise contamination risks and will house a new twin-screw compounding line with gravimetric feeders and advanced monitoring systems adopted for medical production.
The company produced their first medical compounds in the 1990s and launched the Mediprene range of TPEs for medical applications in 2004. Continuous investment in technology, people and processes contributed to the company becoming the 1st TPE compounder in Europe to gain the ISO 13485 accreditation in 2007.
Construction of the new production hall began in September 2021. The aim is to complete the project by autumn 2022.
Georg Brunstam, President and CEO HEXPOL Group, commented, “This investment confirms HEXPOL’s ongoing commitment to this important product area. For the team in Åmål, it’s part of their continuing story and development. HEXPOL invest to ensure we deliver the know-how, performance and reliability our customers deserve.“
